Evaluation of multiple sclerosis diagnostic criteria in Suzhou, China – risk of under-diagnosis in a low prevalence area
Cheng X-J, Cheng Q, Xu L-Z, Zhao H-Q, Zhao Z, Wang W, Jiang G-X, Fredrikson S. Evaluation of multiple sclerosis diagnostic criteria in Suzhou, China – risk of under-diagnosis in a low prevalence area. Acta Neurol Scand: 2010: 121: 24–29.
© 2009 The Authors Journal compilation © 2009 Blackwell Munksgaard. Objective –
To evaluate the discharge diagnosis of demyelinating diseases in the central nervous system (CNS) and analyze the predictive value of the new diagnostic criteria in Suzhou, China. Materials and methods –
We collected clinical information and data of laboratory examinations for all cases with a diagnosis of various demyelinating diseases in the CNS. All data were reviewed individually by four senior neurologists, and a diagnosis was finally given to each patient according to the McDonald criteria and the Poser criteria for multiple sclerosis (MS). Results –
In the analysis, 176 patients with a diagnosis of demyelinating diseases in the CNS at discharge were included. In 82 patients with a diagnosis of MS at discharge, the MS diagnosis was confirmed for 74 patients according to the McDonald criteria for MS, and the positive predictive value for the discharge diagnosis of MS was 90.2% (74/82). According to the Poser criteria, 61 patients were diagnosed as MS. The consistency of the two diagnostic criteria for MS was 78.4%, based on the results of the evaluation. Conclusions –
Under-diagnosis of MS could be one of the explanations for the low prevalence of MS in China. Compared to the Poser criteria, the McDonald criteria had a higher sensitivity for the diagnosis of MS.
Document Type: Research Article
Department of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, China
Department of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou, China
Department of Neurology, Suzhou No. 4 People’s Hospital, Suzhou, China
Department of Neurology, Suzhou No. 2 People’s Hospital, Suzhou, China
Division of Neurology, Department of Clinical Neuroscience, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden
Publication date: January 1, 2010